Jamal Musiala returned to the pitch on Friday, November 20, playing the final minutes of Bayern Munich’s 1-1 draw against Cologne, as sport.es reported.
The player suffered two fainting spells during pre-season in August due to a neurological dysfunction characterized by brief absence seizures, according to sport.es. The condition demands ongoing pharmacological treatment and continuous medical monitoring. At 23 years of age, the German international faces a health problem that extends far beyond standard muscular injuries. In July 2025, he suffered a severe leg and ankle injury during the Club World Cup that sidelined him for months, according to Sport.
In September 2026, a right thigh muscle injury further halted his progression. The neurological disorder caused sudden episodes of altered consciousness and fainting on the field, raising doubts regarding his sporting future and triggering a public clash between Bayern Munich and FIFPRO, the international players’ union. FIFPRO rejected the remarks made by club officials and defended the player.
Karl-Heinz Rummenigge, a member of Bayern Munich’s supervisory board, questioned whether the German international can regain his previous form after these health issues, according to Goal. “Sospechamos que le será difícil volver a su nivel anterior,” Rummenigge said, as elespectador.com noted. Days earlier, Rummenigge had described the neurological dysfunction diagnosed in August as an incurable disease.
#FIFPRO is deeply concerned by the repeated public statements from FC Bayern Munich’s leadership calling into question the contract of Jamal Musiala as he returns from injury.https://t.co/uPTxfY2lUt
Uli Hoeness, the club’s honorary president, also addressed the situation on the BR network’s Sunday Roundtable, noting that the condition is not easy to cure with medication alone. In response to these remarks, FIFPRO stepped in to defend the player, rejecting the club officials’ public doubts, elespectador.com reported.
Medication Fails to Fully Control Musiala's Seizures and Side Effects
The daily management of Jamal Musiala’s health remains a complex challenge for the medical staff, as the use of various medications has not fully prevented recurrent side effects or guaranteed his uninterrupted availability, according to reporting by Goal. These persistent difficulties interrupt his training consistency and restrict his capacity to reach peak physical and technical form on a regular basis.

Goal also said that the ongoing pharmacological treatment cannot eliminate the constant threat of missed matches, complicating the coaching staff’s planning.
Syndicate Defense and Medical Realities
Sport.es pointed out that sudden disconnects and postural drops pose severe risks in elite football, a sport demanding constant concentration, rapid reflexes, and high-speed coordination. Despite these dangers, medical experts emphasize that absence seizures can respond favorably to medication, allowing certain individuals to lead entirely normal lives.
In response to club officials questioning the player’s future, FIFPRO intervened publicly to support the athlete and rejected the remarks made by leadership, as reported by EFE and Ronald Wittek. Sport.es added that full clinical prognostic details remain restricted, leaving exact individual recovery timelines uncertain.
Bayern Weighs Musiala's Contract Value Against Limited Playing Time
Musiala signed a lucrative contract in February 2025 that runs until 2030, carrying an annual salary estimated at over 25 million euros including bonuses, eltiempo.com reported. Sky Sport added that the agreement contains a departure clause that could activate in the summer of 2027.

Club executives are now weighing that massive investment against the player’s recent lack of regular playing time. Bayern Munich has managed a complicated stretch involving injuries and illnesses, though recent results have secured the Bundesliga lead. Rummenigge emphasized that management must hold direct talks with the player, his family, and his representatives regarding financial adjustments during prolonged slumps.
“Hay que hablar con la familia, el jugador y, con todo el respeto, la agencia, porque entonces esas cifras ya no son viables,” Rummenigge said, according to elespectador.com.
Despite the ongoing tension, club leadership considers an immediate transfer unlikely given the current uncertainty surrounding his medical profile. Rummenigge said that the board does not view a departure as viable right now and doubted whether any other team would attempt a signing under these circumstances.